| __timestamp | MiMedx Group, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 105558000 | 580006000 |
| Thursday, January 1, 2015 | 167094000 | 676585000 |
| Friday, January 1, 2016 | 212608000 | 778966000 |
| Sunday, January 1, 2017 | 285920000 | 671251000 |
| Monday, January 1, 2018 | 322725000 | 463508000 |
| Tuesday, January 1, 2019 | 256174000 | 445724000 |
| Wednesday, January 1, 2020 | 208904000 | 399725000 |
| Friday, January 1, 2021 | 215332000 | 296656000 |
| Saturday, January 1, 2022 | 219525000 | 293122000 |
| Sunday, January 1, 2023 | 266843000 | 268323000 |
| Monday, January 1, 2024 | 304979000 |
Data in motion
In the competitive landscape of pharmaceuticals, understanding financial health is crucial. This analysis delves into the gross profit trends of Taro Pharmaceutical Industries Ltd. and MiMedx Group, Inc. from 2014 to 2023. Taro consistently outperformed MiMedx, with its gross profit peaking in 2016 at approximately 780 million, a staggering 37% higher than MiMedx's peak in 2018. However, Taro's profits saw a decline, dropping by 65% from 2016 to 2023. MiMedx, on the other hand, experienced a more stable trajectory, with a 153% increase from 2014 to 2018, before stabilizing around 220 million in recent years. The data for 2024 is incomplete, but Taro shows signs of recovery. This comparison highlights the dynamic nature of the pharmaceutical industry, where strategic decisions and market conditions significantly impact financial outcomes.
Gross Profit Analysis: Comparing Pfizer Inc. and Taro Pharmaceutical Industries Ltd.
Bristol-Myers Squibb Company vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown
Vertex Pharmaceuticals Incorporated vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and MiMedx Group, Inc.
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Trends
Who Generates Higher Gross Profit? Grifols, S.A. or Taro Pharmaceutical Industries Ltd.
Alkermes plc vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.
Gross Profit Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd.
Annual Revenue Comparison: Taro Pharmaceutical Industries Ltd. vs MiMedx Group, Inc.
Comparing Cost of Revenue Efficiency: Taro Pharmaceutical Industries Ltd. vs MiMedx Group, Inc.